Tumor-induced immune dysfunction: The macrophage connection

Journal of Leukocyte Biology

Volumn 64, Issue 3, 1998, Pages 275-290

  Elgert, Klaus D ^a   Alleva, David G ^a,b   Mullins, David W ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotactic molecules; Cytokines; Growth factors; Proteases

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1;

CYTOTOXICITY; HOST SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 0031709864     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.3.275     Document Type: Review

References (217)

1. Elgert, K. D., Farrar, W. L. (1978) Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. J. Immunol. 120, 1345-1353.
2. Farrar, W. L., Elgert, K. D. (1978) Inhibition of mitogen and immune blastogenesis by two distinct populations of suppressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression. Int. J. Cancer 22, 142-151.
3. Yurochko, A. D., Nagarkatti, P. S., Nagarkatti, M., Elgert, K. D. (1989) Tumor-induced alterations in macrophage accessory activity on autoreactive T cells. Cancer Immunol. Immunother. 30, 170-176.
4. + T cells to suppress recognition of allogenic and syngeneic MHC class II molecules. J. Leukoc. Biol. 52, 661-669.
5. Alleva, D. G., Askew, D., Burger, C. J., Elgert, K. D. (1993) Fibrosarcoma-induced increase in macrophage tumor necrosis factor a synthesis suppresses T cell responses. J. Leukoc. Biol. 54, 152-160.
6. Walker, T. M., Burger, C. J., Elgert, K. D. (1994) Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cell. Immunol. 154, 342-357.
7. 2. J. Immunol. 153, 1674-1686.
8. 1: contrasting effects on resting and activated macrophages. J. Leokoc. Biol. 57, 919-928.
9. Connolly, K. M., Elgert, K. D. (1979) Concentration-dependent role of macrophages in MLR regulation: elaboration of nondialyzable heat stable inhibitor and heat labile enhancing factors. J. Reticuloendothel. Soc. 25, 243-253.
10. Connolly, K. M., Elgert, K. D. (1979) Regulation of T cell mixed lymphocyte reaction reactivity: demonstration of enhancing and inhibitory activity in tumor-bearing host macrophage supernatants. Cell. Immunol. 45, 94-107.
11. Connolly, K. M., Elgert, K. D., Conroy, J. M., Vogel, S. N., Rutherford, R. B. (1983) Immunoregulation of the mixed lymphocyte reaction by macrophage-derived factors: functional and biochemical separation of enhancing and inhibitory factors. Immunobiol. 164, 144-159.
12. Malick, A. P., Garner, R. E., Black, S. P., Elgert, K. D. (1984) Normal and tumor-bearing host macrophage factor-mediated modulation of mixed lymphocyte reaction responsiveness: separation of T lymphocyte subset susceptibility to enhancing and inhibitory factors. Cell. Immunol. 85, 549-555.
13. Mills, C. D., Shearer, J., Evans, R., Caldwell, M. D. (1992) Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol. 149, 2709-2714.
14. Schechter, G. P., Wahl, L. M., Oppenheim, J. J. (1979) Suppressor monocytes in human disease: a review. Adv. Exp. Med. Biol. 121B, 283-298.
15. Herberman, R. B., Holden, H. T., Djeu, J. Y., Jerrells, T. R., Varesio, L., Tagliabue, A., White, S. L., Oehler, J. R., Dean, J. H. (1980) Macrophages as regulators of immune responses against tumors. Adv. Exp. Med. Biol. 121B, 361-379.
16. Fidler, I. J., Schroit, A. J. (1988) Recognition and destruction of neoplastic cells by activated macrophages: discrimation of altered self. Biochim. Biophys. Acta 948, 151-173.
17. Bonta, I. L., Ben-Efraim, S. (1993) Involvement of inflammatory mediators in macrophage antitumor activity. J. Leukoc. Biol. 54, 613-626.
18. Grabbe, S., Bruvers, S., Beissert, S., Granstein, R. D. (1994) Interferon-γ inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Leukoc. Biol. 55, 695-701.
19. Blachere, N. E., Li, Z., Chandawarkar, R. V., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., Srivastava, P. K. (1997) Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186, 1315-1322.
20. Evans, R. (1978) Macrophage requirement for growth of a murine fibrosarcoma. Br. J. Cancer 37, 1086-1089.
21. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., Ruco, L. (1992) The origin and function of tumor-associated macrophages. Immunol. Today 13, 265-270.
22. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., Sorg, C. (1994) Macrophages and angiogenesis. J. Leukoc. Biol. 55, 410-422.
23. Parajuli, P., Singh, S. M. (1996) Alteration in IL-1 and arginase activity of tumor-associated macrophages: a role in the promotion of tumor growth. Cancer Lett. 107, 249-256.
24. Elgert, K. D., Farrar, W. L. (1978) In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells. Cell. Immunol. 40, 356-364.
25. Aoe, T., Okamoto, Y., Saito, T. (1995) Activated macrophages induce structural abnormalities of the T cells receptor-CD3 complex. J. Exp. Med. 181, 1881-1886.
26. Aso, H., Tamura, K., Yoshie, O., Nakamura, T., Kikuchi, S., Ishida, N. (1992) Impaired NK response of cancer patients to IFN-α but not to IL-2: correlation with serum immunosuppressive acidic protein (IAP) and role of suppressor macrophage. Microbiol. Immunol. 36, 1087-1097.
27. Evans, R., Duffy, T. M., Blake, S. S., Lin, H-S. (1989) Regulation of systemic macrophage IL-1 gene transcription: the involvement of tumor-derived macrophage growth factor, CSF-1. J. Leukoc. Biol. 46, 428-433.
28. Fauve, R. M (1993) Macrophages and cancer: some aspects of the macrophage-cancer relationship. Res. Immunol. 144, 265-268.
29. Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., Sporn, M. B. (1987) Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788-5792.
30. Mantovani, A., Ming, W. J., Balotta, C., Abdeljalil. B., Bottazzi, B. (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim. Biophys. Acta 865, 59-67.
31. Nathan, C. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319-326.
32. Dinapoli, M. R., Calderon, C. L., Lopez, D. M. (1996) The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J. Exp. Med. 183, 1323-1329.
33. Leek, R. D., Harris, A. L., Lewis, C. E. (1994) Cytokine networks in solid human tumors: regulation of angiogenesis. J. Leukoc. Biol. 56, 423-435.
34. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., Harris, A. L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56, 4625-4629.
35. Vassalli, P. (1992) The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452.
36. Beissert, S., Bergholz, M., Waase, L. Lepsien, G., Schauer, A., Pfizenmaier, K., Kronke, M. (1989) Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization. Proc. Natl. Acad. Sci. USA 86, 5064-5068.
37. van Netten, J. P., Ashmead, B. J., Parker, R. L., Thornton, I. G., Fletcher, C., Cavers, D., Coy, P., Brigden, M. L. (1993) Macrophage-tumor cell associations: a factor in metastasis of breast cancer? J. Leukoc. Biol. 54, 360-362.
38. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., Blay, J. Y. (1997) The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today 18, 493-497.
39. Kamo, I., Friedman. H. (1977) Immunosuppression and the role of suppressive factors in cancer. Adv. Cancer Res. 25, 271-321.
40. Alleva, D. G., Burger, C. J., Elgert, K. D. (1994) Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression. Oncology Res. 6, 219-228.
41. Young, M. R., Wright, M. A., Matthews, J. P., Malik, I., Prechel, M. (1996) Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. J. Immunol. 156, 1916-1922.
42. Essner, R., Rhoades, K., McBride, W. H., Morton, D. L., Economou, J. S. (1989) IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142, 3857-3861.
43. 2. Proc. Natl. Acad. Sci. USA 86, 3803-3807.
44. Nishioka, Y., Sone, S., Okubo, A., Ogura, T. (1990) Suppression by interleukin-4 of activation of human blood monocytes to the tumoricidal state. Jpn. J. Cancer Res. 81, 936-941.
45. Platzer, C., Richter, G., Uberla, K., Hock, H., Diamantstein, T., Blankenstein, T. (1992) Interleukin-4-mediated tumor suppression in nude mice involves interferon-γ. Eur. J. Immunol. 22, 1729-1733.
46. Bogdan, C., Nathan. C. (1993) Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685, 713-739.
47. Holler, W., Kalthoff, F. S., Majdic, O., Knapp, W. (1993) Interleukin-4 production by the malignant cell line HUT78. Lymphokine Cytokine Res. 12, 33-38.
48. Colombo, M. P., Forni, G. (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today 15, 48-51.
49. Zhou, Y., Lin, G., Baarsch, M. J., Scamurra, R. W., Murtaugh, M. P. (1994) Interleukin-4 suppresses inflammatory cytokine gene transcription in porcine macrophages. J. Leukoc. Biol. 56, 507-513.
50. Suk, K., Somers, S. D., Erickson, K. L. (1993) Regulation of murine macrophage function by IL-4: IL-4 and IFN-γ differentially regulate macrophage tumoricidal activation. Immunology 80, 617-624.
51. Utsumi, K., Takai, Y., Tada, T., Ohzeki, S., Fujiwara, H., Hamaoka, T. (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J. Immunol. 145, 397-403.
52. Zhou, D., Munster, A., Winchurch, R. A. (1991) Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-β. FASEB J. 5, 2582-2585.
53. Jourdan, M., Zhang, X. G., Portier, M., Boiron, J.-M., Bataille, R., Klein, B. (1991) IFN-α induces autocrine production of IL-6 in myeloma cell lines. J. Immunol. 147, 4402-1407.
54. Lu, C., Vickers, M. F., Kerbel, R. S. (1992) Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. Natl. Acad. Sci. USA 89, 9215-9219.
55. Ahn, M. C., Siziopikou, K. P., Plate, J. M., Casey, L., Silver, M., Harris, J. E., Braun, D. P. (1997) Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6. Cancer Immunol. Immunother. 45, 37-44.
56. Oswald, I. P., Gazzinelli, R. T., Sher, A., James, S. L. (1992) IL-10 syngerizes with IL-4 and TGF-β to inhibit macrophage cytotoxic activity. J. Immunol. 148, 3578-3582.
57. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., Mosmann, T. R. (1993) Interleukin-10. Annu. Rev. Immunol. 11, 165-190.
58. Richter, G., Kruger-Krasagakes, S., Hein. G., Huls, C., Schmitt, E., Diamantstein, T., Blankenstein, T. (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53, 4134-4137.
59. Nabioullin, R., Sone, S., Mizuno, K., Yano, S., Nishioka, Y., Haku, T., Ogura, T. (1994) Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukoc. Biol. 55, 437-442.
60. Wang, L., Goillot, E., Tepper, R. I. (1994) IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell Immunol. 159, 152-169.
61. Srimal, S., Nathan, C. F. (1990) Purification of macrophage deactivating factor. J. Exp. Med. 171, 1347-1361.
62. Tsunawaki, S., Nathan, C. F. (1986) Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium. J. Exp. Med. 164, 1319-1331.
63. Young, M. R. I., Wright, M. A.. Coogan, M., Young, M. E., Bagash, J. (1992) Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppresson through transforming growth factor-β. Cancer Immunol. Immunother. 35, 14-18.
64. McCartney-Francis, N. L., Wahl, S. M. (1994) Transforming growth factor β: a matter of life and death. J. Leukoc. Biol. 55, 401-409.
65. De Larco, J. E., Todaro, G. J. (1978) Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 75, 4001-4005.
66. 1 regulation of macrophage activation depends on the triggering stimulus. J. Leukoc. Biol. 54, 423-429.
67. 1 inhibits both endotoxin-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophages. J. Leukoc. Biol. 55, 192-200.
68. Haridas, V., Darnay, B. G., Natarajan, K., Heller, R., Aggarwal, B. B. (1998) Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation. J. Immunol. 160, 3152-3162.
69. Boutard, V., Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J-P., Baud, L. (1995) Transforming growth factor-β stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J. Immunol. 155, 2077-2084.
70. Ting, C-C., Rodrigues, D. (1982) Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. J. Natl. Cancer Inst. 69, 867-872.
71. Young, M. R. I., Young, M. E., Wright, M. A. (1990) Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors. Exp. Hematol. 18, 806-811.
72. Kurland, J. I., Pelus, L. M., Ralph, P., Bockman, R. S., Moore, M. A. S. (1979) Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role of colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc. Natl. Acad. Sci. USA 76, 2326-2330.
73. Evans, R., Duffy, T., Cullen, R. T. (1984) Tumor-associated macrophages stimulate the proliferation of murine tumor cells surviving treatment with the oncolytic cyclophosphamide analogue astaz-7557: in vivo implications. Int. J. Cancer 34, 883-890.
74. Wing, E. J., Magee, D. M., Pearson, A. C., Waheed, A., Shadduck, R. K. (1986) Peritoneal macrophages exposed to purified macrophage colony-stimulating factor (M-CSF) suppress mitogen-and antigen-stimulated lymphocyte proliferation. J. Immunol. 137, 2768-2773.
75. Sakata, T., Iwagami, S., Tsuruta, Y., Teraoka, H., Suzuki, S., Suzuki, R. (1992) Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice. J. Immunol. 149, 4002-1008.
76. 2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J. Leukoc. Biol. 53, 86-92.
77. Kimura, F., Douzono, M., Ohta, J., Morita, T., Ikeda, K., Nakamura, Y., Sato, K., Yamada, M., Nagata, N., Motoyoshi, K. (1996) Augmentation of antitumor immunity using genetically M-CSF-expressing L1210 cells. Exp. Hematol. 24, 360-363.
78. Hart, P. H., Whitty, G. A., Piccoli, D. S., Hamilton, J. A. (1988) Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-γ: increased TNF-α but not IL-1 activity. J. Immunol. 141, 1516-1521.
79. Tsuchiya, Y., Igarashi, M., Suzuki, R., Kumagai, K. (1988) Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J. Immunol. 141, 699-708.
80. Fu, Y.-X., Watson, G. A., Kasahara, M., Lopez, D. M. (1991) The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J. Immunol. 146, 783-789.
81. Sotomayor, E. M., Fu, Y-X., Lopez-Cepero, M., Herbert, L., Jimenez, J. J., Albarracin, C., Lopez, D. M. (1991) Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. J Immunol. 147, 2816-2823.
82. Walker, T. M., Burger, C. J., Elgert, K. D. (1993) Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of syngeneic MHC class II molecules. Oncology Res. 4, 455-465.
83. Ragnhammar, P. (1996) Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors. Med. Oncol. 13, 167-176.
84. Taffet, S. M., Russell, S. W. (1981) Macrophage-mediated tumor cell killing: regulation of expression of cytotoxic activity by prostaglandin E. J. Immunol. 126, 424-427.
85. Young, M. R., Knies, S. (1984) Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo. J. Natl. Cancer Inst. 72, 919-922.
86. Hubbard, W. C., Alley, M. C., McLemore, T. L., Boyd, M. R. (1988) Profiles of prostaglandin synthesis in sixteen established cell lines derived from human lung, colon, prostate and ovarian tumors. Cancer Res. 48, 4770-4775.
87. Gardner, T. E., Naama, H., Daly, J. M. (1995) Peritoneal and splenic macrophage functions in the tumor-bearing host. J. Surg. Res. 59, 305-310.
88. Bottazzi, B., Walter, S., Govoni, D., Colotta, F., Mantovani, A. (1992) Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148, 1280-1285.
89. Bluestone, J. A., Lopez, C. (1983) Suppression of the immune response in tumor-bearing mice. III. Induction of functionally suppressive antigen-driven macrophages. Cancer Invest. 1, 5-13.
90. Janicke, R., Mannel, D. N. (1990) Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. J. Immunol. 144, 1144-1150.
91. Zembala, M., Siedlar, M., Marcinkiewicz, J., Pryjma, J. (1994) Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol. 24, 435-439.
92. Urban, J. L., Schreiber, H. (1992) Tumor antigens. Annu. Rev. Immunol. 10, 617-644.
93. Ting, C. C., Rodrigues, D. (1980) Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance. Proc. Natl. Acad. Sci. USA 77, 4265-4269.
94. Watson, G. A., Lopez, D. M. (1995) Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. J. Immunol. 155, 3124-3134.
95. + T cells and macrophages. Scand. J. Immunol. 37, 111-115.
96. Liotta, L. A (1992) Cancer cell invasion and metastasis. Sci. Am. 266, 54-69.
97. Springer, T. A. (1990) Adhesion receptors of the immune system. Nature 346, 425-434.
98. Takemura, R., Werb, Z. (1984) Secretory products of macrophages and their physiological functions. Am. J. Physiol, 246, C1-C9.
99. Cameron, D. J. (1983) Inhibitory factors derived from human tumors: isolation of factors which suppress macrophage mediated cytotoxicity. Int. J. Immunopharmacol. 5, 345-352.
100. Gifford, G. E., Loewenstein, J., Yamin, A., Gallily, R. (1986) Correlation of macrophage-mediated tumor-cell lysis with the production of macrophage cytolytic factor (CF). Preliminary characterization of a factor inhibiting CF production. Int. J. Cancer 37, 73-79.
101. Denis, M., Ghadirian, E. (1990) Human monocyte tumouristatic ability -Modulation by cytokines and tumour cell products. Int. J. Immunopharmacol. 12, 509-513.
102. Cianciolo, G. J. (1993) Macrophages and cancer anti-inflammatory effects of neoplasms. Res. Immunol. 144, 268-271.
103. Evans, R., Kamdar, S. J., Duffy, T. M. (1991) Tumor-derived products induce IL-1α, IL-1β, TNF-α, and 1L-6 gene expression in murine macrophages: distinctions between tumor-and bacterial endotoxin-induced gene expression. J. Leukoc. Biol. 49, 474-482.
104. Gemsa, D., Kramer, W., Napierski, I., Barlin, E., Till, G., Resch, K. (1981) Potentiation of macrophage tumor cytostasis by tumor-induced ascites. J Immunol. 126, 2143-2150.
105. Larrick, J. W., Wright, S. C. (1990) Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4, 3215-3223.
106. Moncada, S., Palmer, R. M. J., Hibbs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
107. MacMicking, J., Xie, Q.-W., Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
108. Kono, K., Salazar-Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., Kiessling, R. (1996) Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 26, 1308-1313.
109. Berton G., Dusi, S., Bellavite, P. (1988) The respiratory burst of phagocytes. In The Respiratory Burst and Its Physiological Significance (A. J. Sbarro and R. R. Strauss, eds.). New York: Plenum Press. 33-52.
110. Hoffman, R. A., Langrehr, J. M., Billiar, T. R., Curran, R. D., Simmons, R. L. (1990) Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J. Immunol. 145, 2220-2226.
111. Hasday, J. D., Shah, E. M., Lieberman, A. P. (1990) Macrophage tumor necrosis factor-α release is induced by contact with some tumors. J. Immunol. 145, 371-379.
112. Debets, J. M. H., Van der Linden, C. J., Dieteren, I. E. M., Leeuwenberg J. F. M., Buurman, W. A. (1988) Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J. Immunol. 141, 1197-1201.
113. Debets, J. M. H., Van de Winkel, J. G. J., Ceuppens, J. L., Dieteren, I. E. M., Buurman, W. A. (1990) Cross-linking of both FcγRI and FcγRII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-FcγR interactions: functional activation of FcγRII by treatment with proteases or neuramindase. J. Immunol. 144, 1304-1310.
114. Johnson, R. J., Siliciano, R. F., Shin, H. S. (1979) Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors. J. Immunol. 122, 379-382.
115. Wallace, P. K., Howell, A. L., Fanger, M. W. (1994) Role of Fcγ receptors in cancer and infectious disease. J. Leukoc. Biol. 55, 816-826.
116. Burger, C. J., Elgert, K. D. (1983) Level of macrophage induction during tumor growth: primed or activated? Immunol. Commun. 12, 285-290.
117. Duffie, G. P., Young, M. R. I. (1991) Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma. J. Leukoc. Biol. 49, 8-14.
118. 2: changes in macrophage suppressor activity. J. Leukoc. Biol. 53, 550-558.
119. 2 Ia, and tumor necrosis factor-α. Immunopharmacol. 25, 215-227.
120. Muffins, D. W., Alleva, D. G., Burger, C. J., Elgert, K. D. (1997) Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacol. 37, 63-73.
121. 2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J. Leukoc. Biol 44, 474-484.
122. Nelson, J. A. S., Parhar, R. S., Scodras, J. M., Lala, P. K. (1990) Characterization of macrophage subsets regulating murine natural killer cell activity. J. Leukoc. Biol. 48, 382-393.
123. Sotomayor, E. M., DiNapoli, M. R., Calderon, C., Colsky, A., Fu, Y. X., Lopez, D. M. (1995) Decreased macrophage-mediated cytotoxicity in mammary-tumor-bearing mice is related to alteration of nitric-oxide production and/or release. Int. J. Cancer 60, 660-667.
124. Alleva, D. G., Askew, D., Burger, C. J., Elgert, K. D. (1994) Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms. Immunol. Invest. 23, 457-472.
125. Fisher, R. I., Bostick-Bruton, F. (1982) Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide. J. Immunol. 129, 1770-1774.
126. Adams, D. O., Hamilton, T. A. (1987) The cell biology of macrophage activation. Immunol. Rev. 97, 5-27.
127. Klostergaard, J. (1993) Macrophages and cancer: macrophage tumoricidal mechanisms. Res. Immunol. 144, 274-276.
128. Levy, J. P., Leclerc, J. C. (1975) Immune rejection of tumor cells: in vivo significance of anti-tumor in vitro immune reactions. Biomed. 22, 249-254.
129. Tomazic, V. J., Farha, M., Loftus, A., Elias, E. G. (1988) Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro. J. Immunol. 140, 4056-4061.
130. Kloke, O., Niederle, N. (1990) Development and mechanisms of interferon resistance. Cancer Treat. Rev. 17 (Suppl. A), 81-88.
131. Cameron, D. J., Rittenbury, M., Majeski, J. (1984) Ability of cancer patients' macrophages to kill autologous tumor targets. Effects of prostaglandin inhibitors on cytotoxicity. Cancer 53, 2053-2057.
132. 2 production of monocytes in bladder cancer patients. Cancer 64, 2076-2080.
133. Ding, A., Sanchez, E., Nathan, C. F. (1993) Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J. Immunol. 151, 5596-5602.
134. Webb, D. S. A., Shimizu, Y., Van Seventer, G. A., Shaw, S., Gerrard, T. L. (1990) LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249, 1295-1297.
135. Moore, K., McBride, W. H. (1980) The activation state of macrophage subpopulations from a murine fibrosarcoma. Int. J. Cancer 26, 609-616.
136. + Mφ with immunosuppressive activity. Cell. Immunol. 108, 255-268.
137. Yurochko, A. D., Burger, C. J., Elgert, K. D. (1990) Tumor modulation of autoreactiyity: decreased macrophage and autoreactive T cell interactions. Cell Immunol. 127, 105-119.
138. Kirchner, H., Chused. T. M., Herberman, R., Holden, H. T., Lavrin, U. (1974) Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J. Exp. Med. 139, 1473-1787.
139. Kirchner, H., Herberman, R. B., Glaser, M., Lavrin, D. H. (1974) Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney Sarcoma Virus-induced tumors. Cell. Immunol. 13, 32-40.
140. Kirchner, H., Muchmore, A. V., Chused, T. M., Holden, H. T., Herberman, R. B. (1975) Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. J. Immunol. 114, 206-210.
141. Glaser, M., Kirchner, H., Herberman, R. B. (1975) Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross Leukemia Virus included tumors. Int. J. Cancer 16, 384-389.
142. Eggers, A. E., Wunderlich, J. R. (1975) Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens. J. Immunol. 114, 1554-1556.
143. Pope, B. L., Whitney, R. B., Levy, J. G., Kilburn, D. G. (1976) Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor cell population. J. Immunol. 116, 1342-1346.
144. Oehler, J. R., Herberman, R. B., Campbell, D. A., Jr., Djeu, J. Y. (1977) Inhibition of rat mixed lymphocyte cultures by suppressor macrophages. Cell. Immunol. 29, 238-250.
145. Farrar, W. L., Elgert, K. D. (1978) Suppressor cell activity in tumor-bearing mice. II. Inhibition of DNA synthesis and DNA polymerases by TBH splenic suppressor cells. J. Immunol. 120, 1354-1361.
146. Farrar, W. L., Elgert, K. D., Foo, S-Y. (1981) Suppressor cell activity in tumor-bearing mice. III. Co-purification of a factor inhibiting DNA polyermase activity. J. Immunol. 127, 2339-2344.
147. Pope, B. L., Whitney, R. B., Levy, J. G. (1978) Two distinct populations of suppressor cells in the spleens of mice bearing methylcholanthrene-induced tumors. J. Immunol. 120, 2033-2040.
148. Unanue, E. R., Allen, P. M. (1987) The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236, 551-557.
149. 2-producing suppressor macrophages. Immunobiol. 161, 385-391.
150. Ye, Q. W., Mokyr, M. B., Pyle, J. M., Dray, S. (1984) Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor. Cancer Immunol. Immunother. 16, 162-169.
151. Jessup, J. M., Grue, L J., Kahan, B. D., Pellis, N. R. (1985) Induction of suppressor cells by a tumor-derived suppressor factor. Cell. Immunol. 93, 9-25.
152. Fujii, T., Igarashi, T., Kishimoto, S. (1987) Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. J. Natl. Cancer Inst. 78, 509-517.
153. Eisenstein, T. K. (1994) Suppressor macrophages. Immunol. Ser. 60, 203-224.
154. Yurochko, A. D., Pyle, R. H., Elgert, K. D. (1989) Changes in macrophage populations: phenotypic differences between normal and tumor-bearing host macrophages. Immunobiol. 178, 416-4-35.
155. + T cell activity. J. Immunol. 148, 648-655.
156. + autoreactive T cells. Immunol. Invest. 22, 169-187.
157. Beun, G. D. M., van de Velde, C. J. H., Fleuren, G. J. (1994) T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition? Immunol. Today 15, 11-15.
158. H2 lymphokines. J. Immunol. 146, 108-113.
159. Powri, F., Menon, S., Coffman, R. L. (1993) Cooperation between IL-4 and IL-10 results in inhibition of DTH responses. J. Immunol. 150, 203(A).
160. 2 production by lipopolysaccharide-stimulated monocytes. Int. Immunol. 6, 661-664.
161. H2 responses: a key role for the "natural" immune response? Immunol. Today 13, 379-381.
162. Sakata, T., Iwagami, S., Tsuruta, Y., Suzuki, S., Suzuki, R. (1993) Study of natural lipocortin I: a potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice. J. Immunol. 151, 4964-4972.
163. + macrophages: tumor-induced population shift. J. Leukoc. Biol. 42, 673-681.
164. Tomioka, H., Saito, H. (1992) Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukoc. Biol. 51, 24-31.
165. Lejeune, P., Lagadec, P., Onier, N., Pinard, D., Ohshima, H., Jeannin, J-F. (1994) Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol. 152, 5077-5083.
166. Mills, C. D. (1991) Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146, 2719-2723.
167. Sieling, P. A., Abrams, J. S., Yamamura, M., Salgame, P., Bloom, B. R., Rea, T. H., Modlin, R. L. (1993) Immunosuppressive roles for IL-10 and IL-4 in human infection: in vitro modulation of T cell responses in leprosy. J Immunol. 150, 5501-5510.
168. Metzger, Z., Hoffeld, J. T., Oppenheim, J. J. (1980) Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol.
169. Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., Sporn, M. B. (1987) Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84, 6020-6024.
170. Tada, T., Ohzeki, S., Utsumi. K., Takiuchi, H., Muramatsu, M., Li, X.-F., Shimizu, J., Fujiwara, H., Hamaoka, T. (1991) Transforming growth factor-β-induced inhibition of T cell function: Susceptibility difference in T cells of various phenotypes and functions and its relevence to immunosuppression in the tumor-bearing host. J. Immunol. 146, 1077-1082.
171. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidnian, C., Proetzel, G., Calvin, D. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
172. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
173. Alleva, D. G., Burger, C. J., Elgert, K. D. (1993) Tumor-induced macrophage tumor necrosis factor-α production suppresses autoreactive T cell proliferation. Immunobiol. 188, 430-445.
174. 2 and nitrite. In in vitro studies. Immunol. Lett. 37, 27-33.
175. Gordon, C., Wofsy, D. (1990) Effects of recombinant murine tumor necrosis factor-α on immune function. J. Immunol. 144, 1753-1758.
176. Micallef, M., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., Kurimoto, M. (1996) Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26, 1647-1651.
177. Brunda, M. J. (1994) Interleukin-12. J. Leukoc. Biol. 55, 280-288.
178. Brunda, M. J., Lusitro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., Gately, M. K. (1993) Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med. 178, 1223-1230.
179. Trinchieri, G., Scott, P. (1994) The role of interleukin 12 in the imune response, disease and therapy. Immunol. Today 15, 460-463.
180. Tahara, H., Zeh, H. J., III, Storkus, W. J., Pappo. I., Watkins, S. C., Gubler, U., Wolf, S. F., Robbins, P. D., Lotze, M. T. (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54, 182-189.
181. Brunda, M. J., Gately, M. K. (1994) Antitumor activity of interleukin-12. Clin. Immunol. Immunopathol. 71, 253-255.
182. Handel-Fernandez, M. E., Cheng, X., Herbert, L. M., Lopez, D. M. (1997) Down-regulation of IL-12, not a shift from T helper-1 to T helper-2 phenotype, is responsible for impaired IFN-γ production in mammary tumor-bearing mice. J. Immunol. 158, 280-286.
183. Rothe, H., Hartmann, B., Geerlings, P., Kolb, H. (1996) Interleukin-12 gene-expression of macrophages is regulated by nitric oxide. Biochem. Biophys. Res. Commun. 224, 159-163.
184. Vodovotz, Y., Bogdan, C. (1994) Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog. Growth Factor. Res. 5, 341-351.
185. Bennett, S., Por, S. B., Cooley, M. A., Breit, S. N. (1993) In vitro replication dynamics of human culture-derived macrophages in long term serum-free system. J. Immunol. 150, 2364-2371.
186. Nicola, N. A. (1989) Hemopoietic cell growth factors and their receptors. Annu. Rev. Biochem. 58, 45-77.
187. Kato, T., Inaba, K., Ogawa, Y., Inaba, M., Kakihara, K., Shimizu, S., Ikehara, S., Sudo, T., Muramatsu, S. (1990) Granulocyte-macrophage colony-stimulating factor enhances macrophage accessory function in Con-A-stimulated T-cell proliferation. Cell. Immunol. 130, 490-500.
188. Fischer, H.-G., Frosch, S., Reske, K., Reske-Kunz, A. B. (1988) Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 141, 3882-3888.
189. Walker, T. M., Yurochko, A. D., Burger, C. J., Elgert, K. D. (1992) Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Immunobiol. 185, 427-439.
190. H1 cytokine synthesis in helminth infection. J. Immunol. 147, 2713-2716.
191. Bogdan, C., Vodovotz, Y., Nathan, C. (1991) Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
192. Garner, R. E., Elgert, K. D. (1986) Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes. J. Leukoc. Biol. 40, 709-724.
193. + macrophages from normal and tumor-bearing hosts: flow cytoflurometrically separated macrophages. Immunobiol. 182, 1-10.
194. Garner, R. E., Malick, A. P., Elgert, K. D. (1986) Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth. J. Leukoc. Biol. 40, 561-574.
195. Elgert, K. D., Askew, D., Burger, C. J. (1991) Identification and isolation of macrophage subpopulations in normal and tumor-bearings using flow cytometry. Applied Fluorescence Tech. 3, 1-9.
196. Yurochko, A. D., Burger, C. J., Elgert, K. D. (1990) Two-color flow cytometric analysis of the expression of Mac and MHC class II antigens on macrophages during tumor growth. Cytometry 11, 725-735.
197. Diesselhoff-den Dulk, M. M. C., van Furth, R. (1981) Characteristics of mononuclear phagocytes from different tissues. In Methods for Studying Mononuclear Phagocytes (D. O. Adams, P. J. Edelson, and H. Koren, eds.), New York: Academic Press, 253-272.
198. Dayan, C. M., Elsegood, K. A., Maile, R. (1997) FasL expression on epithelial cells: the Bottazzo-Feldman hypothesis revisited. Immunol. Today 18, 203.
199. Askew, D., Yurochko, A. D., Burger, C. J., Elgert, K. D. (1990) Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics. Immunol. Lett. 24, 21-30.
200. Walker, T. M., Yurochko, A. D., Burger, C. J., Elgert, K. D. (1992) Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis. Immunol. Lett. 31, 217-226.
201. Alleva, D. G., Elgert, K. D. (1995) Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during cancer. Immunobiol. 192, 155-171.
202. Boraschi, D., Niederhuber, J. E. (1982) Regulation of macrophage suppression and cytotoxicity by interferon: role of Ia-bearing macrophages. J. Immunol. 129, 1854-1858.
203. - macrophages, and their factors. J. Immunol. 140, 1005-1013.
204. Young, M. R., Wheeler, E., Newby, M. (1986) Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. J. Natl. Cancer Inst. 76, 745-750.
205. 2 production and tumoricidal activity but decreases cell surface Ia antigen expression. Cell. Immunol. 134, 31-41.
206. Albina, J. E., Abate, J. A., Henry, W. L., Jr. (1991) Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147, 144-148.
207. Sicher, S. C., Vazquez, M. A., Lu, C. Y. (1994) Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153, 1293-1300.
208. Nelson, J. A. S., Parhar, R. S., Scodras, J. M., Lala, P. K. (1990) Down-regulation of macrophage I-A expression in tumor-bearing mice. J. Leukoc. Biol. 48, 394-402.
209. Askew, D., Burger, C. J., Elgert, K. D. (1993) Tumor-induced modulation of macrophage class II MHC molecule mRNA expression. Mol. Immunol. 30, 911-920.
210. Askew, D., Burger, C. J., Elgert, K. D. (1993) Tumor growth and adherence change the expression of macrophage Mac-2. Cancer Lett. 69, 67-74.
211. Sharon, N., Lis, H. (1989) Lectins as cell recognition molecules. Scienee 246, 227-234.
212. Cherayil, B. J., Chaitovitz, S., Wong, C., Pillai, S. (1990) Molecular cloning of a human macrophage lectin specific for galactose. Proc. Natl. Acad. Sci. USA 87, 7324-7328.
213. Cherayil, B. J., Weiner, S. J., Pillai, S. (1989) The Mac-2 antigen is a galactose-specific lectin that binds IgE. J. Exp. Med. 170, 1959-1972.
214. Woo, H.-J., Shaw, L. M., Messier, J. M., Mercurio, A. M. (1990) The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J. Biol. Chem. 265, 7097-7099.
215. Moutsatsos, I. K., Davis, J. M., Wang, J. L. (1986) Endogenous lectins from cultured cells: subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts. J. Cell Biol. 102, 477-483.
216. Laing, J. G., Wang, J. L. (1988) Identification of carbohydrate binding protein 35 in heterogeneous nuclear ribonucloprotein complex. Biochem. 27, 5329-5334.
217. Raz, A., Pazerini, G., Carmi, P. (1989) Identification of the metastasis-associated, galactose-binding lectin as a chimeric gene product with homology to an IgE-binding protein. Cancer Res. 49, 3489-3493.